For the Inventor, By the Inventor

Enter assignee name

Redwood City, CA, United States of America

Guardant Health, Inc.

USPTO Granted Patents = 123

EPO Patents = 33

Trademarks = 9

Forward Citations = 1,427

Loading Chart...

Loading Chart...

45 inventors (with patents filed for the assignee):

Amirali Talasaz (74 out of 76 patents)

Stefanie Ann Ward Mortimer (53 out of 55 patents)

Helmy A Eltoukhy (51 out of 88 patents)

4. Darya Chudova (26 out of 48 patents)

5. Andrew Kennedy (11 out of 12 patents)

6. Diana Abdueva (11 out of 17 patents)

7. AmirAli Talasaz (11 out of 19 patents)

8. Marcin Sikora (8 out of 8 patents)

9. Ariel Jaimovich (5 out of 5 patents)

10. William J Greenleaf (5 out of 21 patents)

11. Elena Helman (4 out of 4 patents)

12. Catalin Barbacioru (4 out of 10 patents)

13. Mikhail Zhagrov (4 out of 4 patents)

14. Bahram Ghaffarzadeh Kermani (3 out of 28 patents)

15. William Patrick Baird (3 out of 3 patents)

Core Competencies:

Integrated Data Repository

Genetic Variants

Nucleic Acid Analysis

Tumor Mutation Burden

Microsatellite Instability

Cancer Detection

Rare Mutations

DNA Methylation

High Performance Computing

Computational Modeling

Cell-Free DNA

Patient Monitoring

123 patents: Sort by Forward Citations

1. 12500815 - Network bandwidth architecture for bioinformatics system (2025-12-16),

2. 12476013 - Computer architecture for generating an integrated data repository (2025-11-18),

3. 12467087 - Sequencing methods with partitioning (2025-11-11),

4. 12455860 - Data processing abstraction for high performance computing systems (2025-10-28),

5. 12455856 - Single namespace for high performance computing system (2025-10-28),

6. 12435368 - Methods and systems for detecting genetic variants (2025-10-07),

7. 12428670 - Methods and systems for analyzing nucleic acid molecules (2025-09-30),

8. 12385097 - Normalizing tumor mutation burden (2025-08-12),

9. 12359245 - Methods and systems for analyzing nucleic acid molecules (2025-07-15),

10. 12344902 - Microsatellite instability detection in cell-free DNA (2025-07-01),

11. 12340873 - Methods for multi-resolution analysis of cell-free nucleic acids (2025-06-24),

12. D1077824 - Display screen or portion thereof with graphical user interface (2025-06-03),

13. 12322476 - Methods for detecting and suppressing alignment errors caused by fusion events (2025-06-03),

14. 12319968 - Gene mutations and copy number alterations of EGFR, KRAS and MET (2025-06-03),

15. 12319961 - Methods and systems for detecting genetic variants (2025-06-03),

Guardant Health, Inc. is a leading precision oncology company focused on helping conquer cancer globally through non-invasive cancer screening tests, genomic analysis, and advanced diagnostics. The company's flagship product, Guardant360®, is a comprehensive liquid biopsy test that enables advanced cancer detection and monitoring.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

123 Patents

#14 in Redwood City, CA

#702 in California

#3,029 in US

#6,313 in the World

Redwood City, CA, United States of America

Guardant Health, Inc.

Forward Citations = 1,427

45 inventors:

Amirali Talasaz (74 out of 76 patents)

Stefanie Ann Ward Mortimer (53 out of 55 patents)

Helmy A Eltoukhy (51 out of 88 patents)

4. Darya Chudova (26 out of 48 patents)

5. Andrew Kennedy (11 out of 12 patents)

Please report any incorrect information to support@idiyas.com

Loading…